Century Therapeutics, Inc. (IPSC) stock
Close on Nov 13, 2026Market cap $298.77MP/E –Yield –
Century Therapeutics statistics
67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 11, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.70
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 101.3%
- 10.8%
- Shares Change (QoQ)
- 0.39%
- 0.50%
- Float
- 174M
- 49M
- Shares Held by Insiders
- 3.78%
- 11.7%
- Shares Held by Institutions
- 87.3%
- 56.4%
Short sellingIndustry
- Short Interest
- 32M
- –
- Short Interest Change
- 9.93%
- -0.80%
- Short % of Float
- 18.4%
- 9.01%
- Short % of Shares Outstanding
- 17.7%
- 6.30%
- Days to Cover
- 30.96
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $3.04
- –
- 52-Week Low
- $0.43
- –
- 20-Day Moving Average
- $1.57
- –
- 50-Day Moving Average
- $1.64
- –
- 200-Day Moving Average
- $2.06
- –
- Average True Range (14)
- $0.16
- –
- Price Change (1 Week)
- -1.79%
- -1.15%
- Price Change (1 Month)
- 10.0%
- -4.87%
- Price Change (3 Months)
- -15.4%
- -21.0%
- Price Change (6 Months)
- -29.5%
- -20.6%
- Price Change (YTD)
- 65.9%
- -23.6%
- Price Change (1 Year)
- 192.9%
- -22.4%
- Price Change (3 Years)
- 26.0%
- -29.5%
- Price Change (5 Years)
- -92.1%
- -77.9%
- Average Volume (10 Days)
- 859,983
- –
- Average Volume (20 Days)
- 971,356
- –
- Average Volume (90 Days)
- 732,555
- –
- Relative Volume
- 0.50
- 0.70
- Relative Strength Index (14)
- 52.3
- 43.4
- Volatility (1 Year)
- 102.7%
- 80.1%
- Beta (5 Years)
- 1.36
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -51.2%
- -49.9%
- Return on Assets (ROA)
- -39.0%
- -40.6%
- Return on Invested Capital (ROIC)
- -125.8%
- -32.9%
- Return on Capital Employed (ROCE)
- -42.7%
- -37.9%
Financial positionIndustry
- Current Ratio
- 8.74
- 3.30
- Quick Ratio
- 8.34
- 2.39
GrowthIndustry
- Revenue Growth (3Y CAGR)
- 175.9%
- 2.25%
EfficiencyIndustry
- Profits Per Employee
- -$1.27M
- -$689.41K
- Employee Count
- 78
- 74
- WACC
- 11.9%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $117.20M
- $17.76M
- Net Cash Per Share
- $0.65
- $0.80
- Equity (Book Value)
- $209.97M
- $53.89M
- Book Value Per Share
- $1.16
- $1.50
- Tangible Book Value
- $175.77M
- $27.13M
- Working Capital
- $108.67M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.67M
- -$1.00M
- FCF Per Share
- -$0.47
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -33.1%
- -21.8%
- FCF Yield
- -28.5%
- -9.44%
- Buyback Yield
- -0.23%
- -0.76%
- Shareholder Yield
- -0.23%
- 0.00%
Scores and fair valueIndustry
- Altman Z-Score
- -2.08
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | IPSC | S&P 500 | Difference | IPSC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +19.6% | -3.0% | +22.6 pts | ||
| 3 months | -14.5% | -2.8% | −11.7 pts | ||
| Year to date | +65.9% | +11.5% | +54.4 pts | ||
| 1 year | +255.2% | +13.5% | +241.8 pts | ||
| 3 years | +28.9% | +77.7% | −48.8 pts | +8.8% | +21.1% |
| 5 years | -92.1% | +72.6% | −164.7 pts | -39.8% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
32M IPSC shares were sold short on Oct 30, 2026, up 9.9% from the previous report, or 18.38% of the shares available to trade. At recent volumes it would take 31.0 days to buy them back. Over the last 20 sessions, 61.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 32,026,662 | +9.9% | 1,034,597 | 31.0 |
| Oct 15, 2026 | 29,133,325 | -0.3% | 996,287 | 29.2 |
| Sep 30, 2026 | 29,218,775 | -0.5% | 573,911 | 50.9 |
| Sep 15, 2026 | 29,354,630 | -0.6% | 373,300 | 78.6 |
| Aug 31, 2026 | 29,528,941 | +0.5% | 418,031 | 70.6 |
| Aug 14, 2026 | 29,370,152 | -1.5% | 573,918 | 51.2 |
| Jul 31, 2026 | 29,815,354 | +5.1% | 732,466 | 40.7 |
| Jul 15, 2026 | 28,381,612 | +21.0% | 1,292,097 | 22.0 |
| Jun 30, 2026 | 23,456,373 | +52.2% | 3,001,790 | 7.8 |
| Jun 15, 2026 | 15,410,355 | +23.6% | 975,904 | 15.8 |
| May 29, 2026 | 12,466,530 | +2.1% | 921,555 | 13.5 |
| May 15, 2026 | 12,209,216 | +1.4% | 653,371 | 18.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?